 "Ranbaxy Q3 net loss at Rs 464.58 cr")
New Delhi: Drug major Ranbaxy today reported a net loss after tax and minority interest of Rs 464.58 crore for the quarter ended 30 September, 2011, on account of foreign exchange losses.
[caption id=“attachment_127466” align=“alignleft” width=“380” caption=“Malvinder Singh, chief executive of Ranbaxy. Reuters”]  [/caption]
The company had posted a net profit of Rs 307.93 crore for the quarter ended 30 September, 2010, Ranbaxy Laboratories said.
Net sales of the company stood at Rs 2,022.75 crore in the quarter ended 30 September, 2011, compared to Rs 1,877.48 crore in the same period of the previous fiscal.
Shares of Ranbaxy laboratories were being quoted at Rs 481 in afternoon trade on the BSE today, down 3.18 percent from their previous close.
PTI
 "Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty")
 "Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched")
 "Who is CP Radhakrishnan, India's next vice-president?")
 "Israel informed US ahead of strikes on Hamas leaders in Doha, says White House")
 "Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty")
 "Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched")
 "Who is CP Radhakrishnan, India's next vice-president?")
 "Israel informed US ahead of strikes on Hamas leaders in Doha, says White House")
](https://images.firstpost.com/wp-content/uploads/2011/11/ranbaxy-reuters.jpg){kind=link}